Felix Beuschlein Selected Research

Hyperaldosteronism (Conn Syndrome)

1/2022	Plasma Steroid Profiling in Patients With Adrenal Incidentaloma.
12/2021	Incidence of Primary Aldosteronism in Patients with Hypokalemia (IPAHK+): Study Design and Baseline Characteristics.
1/2021	Characteristics of preoperative steroid profiles and glucose metabolism in patients with primary aldosteronism developing adrenal insufficiency after adrenalectomy.
1/2021	Altered Taste Perception for Sodium Chloride in Patients With Primary Aldosteronism: A Prospective Cohort Study.
1/2021	Differential effects of reduced mineralocorticoid receptor activation by unilateral adrenalectomy vs mineralocorticoid antagonist treatment in patients with primary aldosteronism - Implications for depression and anxiety.
1/2021	Adrenal Venous Sampling-Guided Adrenalectomy Rates in Primary Aldosteronism: Results of an International Cohort (AVSTAT).
11/2020	The potential pathophysiological role of aldosterone and the mineralocorticoid receptor in anxiety and depression - Lessons from primary aldosteronism.
6/2020	Progress in Primary Aldosteronism 2019: New Players on the Block?
1/2020	Patients With Primary Aldosteronism Respond to Unilateral Adrenalectomy With Long-Term Reduction in Salt Intake.
1/2020	Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Felix Beuschlein Research Topics

Disease

80	Neoplasms (Cancer) 03/2022 - 03/2002
54	Hyperaldosteronism (Conn Syndrome) 01/2022 - 03/2004
52	Adenoma (Adenomas) 01/2022 - 05/2005
38	Cushing Syndrome 07/2022 - 03/2002
26	Adrenocortical Carcinoma 01/2022 - 06/2003
25	Pheochromocytoma 01/2022 - 07/2005
23	Hyperplasia 01/2022 - 03/2012
22	Paraganglioma (Paragangliomas) 01/2022 - 03/2013
20	Hypertension (High Blood Pressure) 03/2022 - 09/2006
12	Pituitary ACTH Hypersecretion 07/2022 - 03/2002
9	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2022 - 01/2013
8	Adrenocortical Adenoma (Disease, Conn's) 01/2020 - 06/2008
7	Carcinogenesis 12/2020 - 06/2003
7	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020 - 02/2010
6	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2008
5	Body Weight (Weight, Body) 11/2020 - 08/2006
4	Type 2 Diabetes Mellitus (MODY) 03/2022 - 07/2005
4	Fabry Disease (Fabry's Disease) 03/2022 - 01/2020
4	Adrenal incidentaloma 01/2022 - 10/2015
4	Muscular Diseases (Myopathy) 05/2021 - 06/2017
4	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2021 - 07/2009
4	Insulin Resistance 05/2020 - 06/2013
4	Essential Hypertension 01/2020 - 06/2013
3	Osteoporosis 01/2022 - 12/2013
3	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2022 - 11/2018
3	Disease Progression 10/2019 - 06/2012
3	Hypogonadism (Hypergonadotropic Hypogonadism) 02/2019 - 05/2009
3	Dosage-sensitive sex reversal 02/2007 - 02/2002
2	COVID-19 01/2022 - 01/2022
2	Atrial Fibrillation 01/2022 - 12/2021
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 12/2015
2	Hypoxia (Hypoxemia) 10/2020 - 04/2017
2	Addison Disease (Addison's Disease) 01/2020 - 02/2019
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020 - 10/2016
2	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2020 - 02/2011
2	Hypothyroidism 02/2019 - 11/2007
2	Obesity 01/2019 - 09/2017

Drug/Important Bio-Agent (IBA)

56	AldosteroneIBA 01/2021 - 03/2004
37	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2022 - 07/2005
21	SteroidsIBA 03/2022 - 06/2003
16	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022 - 03/2002
16	CatecholaminesIBA 01/2022 - 04/2010
14	GlucocorticoidsIBA 01/2022 - 05/2009
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2010
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2010
9	NormetanephrineIBA 01/2022 - 05/2012
9	MetanephrineIBA 10/2020 - 05/2012
8	Antihypertensive Agents (Antihypertensives)IBA 03/2022 - 03/2004
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2004
8	Hormones (Hormone)IBA 01/2022 - 11/2006
8	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 11/2019 - 03/2014
7	Dexamethasone (Maxidex)FDA LinkGeneric 03/2022 - 08/2014
7	Mitotane (Lysodren)FDA Link 01/2022 - 06/2012
7	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2020 - 01/2014
6	3-methoxytyramine (methoxytyramine)IBA 01/2022 - 01/2014
6	PotassiumIBA 12/2021 - 11/2012
6	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 06/2013
6	ReninIBA 06/2020 - 03/2004
6	Succinate Dehydrogenase (Fumarate Reductase)IBA 03/2020 - 10/2014
5	Phosphotransferases (Kinase)IBA 01/2022 - 04/2017
5	Mineralocorticoid Receptor AntagonistsIBA 01/2021 - 11/2012
5	EnzymesIBA 11/2018 - 04/2004
4	GalactosidasesIBA 03/2022 - 01/2020
4	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022 - 04/2017
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
4	Messenger RNA (mRNA)IBA 10/2013 - 05/2005
3	Insulin (Novolin)FDA Link 03/2022 - 06/2013
3	Epinephrine (Adrenaline)FDA LinkGeneric 10/2020 - 02/2015
3	CorticosteroneIBA 01/2020 - 08/2006
3	SaltsIBA 01/2020 - 07/2012
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 02/2007
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 06/2012
3	AndrogensIBA 01/2018 - 01/2013
3	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 12/2017 - 01/2016
3	Dopamine (Intropin)FDA LinkGeneric 08/2017 - 03/2013
3	liposomal doxorubicin (Doxil)FDA Link 10/2016 - 05/2012
3	Liposomes (Liposome)IBA 12/2015 - 02/2010
3	Adenosine Triphosphatases (ATPase)IBA 06/2014 - 04/2013
2	GlycosphingolipidsIBA 03/2022 - 01/2022
2	globotriaosylceramide (globotriosylceramide)IBA 01/2022 - 01/2020
2	Everolimus FDA Link 01/2022 - 11/2019
2	AlpelisibIBA 01/2022 - 11/2019
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2021 - 11/2020
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2019
2	RNA (Ribonucleic Acid)IBA 12/2020 - 10/2010
2	SodiumIBA 01/2020 - 12/2012
2	MineralocorticoidsIBA 01/2020 - 02/2019
2	Cortodoxone (11 Deoxycortisol)IBA 01/2020 - 01/2018
2	PolyaminesIBA 01/2020 - 08/2017
2	LipidsIBA 01/2020 - 01/2020
2	GTP-Binding Proteins (G-Protein)IBA 10/2019 - 01/2014
2	Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA 10/2019 - 04/2018
2	ProlactinIBA 02/2019 - 09/2015
2	FumaratesIBA 01/2019 - 10/2014
2	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2019 - 12/2013
2	Succinic Acid (Succinate)IBA 01/2019 - 10/2014

Therapy/Procedure

30	Therapeutics 03/2022 - 04/2004
28	Adrenalectomy 01/2021 - 11/2012
4	Drug Therapy (Chemotherapy) 02/2018 - 03/2008
3	Aftercare (After-Treatment) 01/2013 - 03/2008